Actos 'Most Substantial' Factor In Man's Cancer, Doc Testifies
Takeda Pharmaceutical Co.'s diabetes drug Actos was "the most substantial causative factor" in a California man's terminal bladder cancer, a urologist testifying for the plaintiff told a Los Angeles jury Tuesday...To view the full article, register now.
Already a subscriber? Click here to view full article